MedTrace Logo

Seated Time for 90% Incidence of Hypotension

NCT03113045 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-04-13

No results posted yet for this study

Summary

The study will determine the 90% effective seated time after intrathecal injection of hyperbaric bupivacaine to avoid hypotension in patients undergoing cesarean delivery.

Conditions

  • Cesarean Section Complications

Interventions

OTHER

seated time

Pt will be seated for a predetermined time period. All Patients will receive intrathecal bupivacaine and morphine.

Sponsors & Collaborators

  • Royal Victoria Hospital, Canada

    lead OTHER

Principal Investigators

  • Albert Moore · McGill University Health Centre/Research Institute of the McGill University Health Centre

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2019-01-31
Completion
2020-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03113045 on ClinicalTrials.gov